BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2033444)

  • 21. [Oncological and endocrine administration of the antiprogestagen RU 486].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2521-4. PubMed ID: 2270126
    [No Abstract]   [Full Text] [Related]  

  • 22. Meningiomas, epidermal growth factor and progesterone.
    Koper JW; Lamberts SW
    Hum Reprod; 1994 Jun; 9 Suppl 1():190-4. PubMed ID: 7962464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas.
    Ragel BT; Couldwell WT; Wurster RD; Jensen RL
    Neurosurg Focus; 2007; 23(4):E10. PubMed ID: 17961034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
    Strassner C; Buhl R; Mehdorn HM
    Neurol Res; 2009 Jun; 31(5):478-82. PubMed ID: 19500450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature.
    Cossu G; Levivier M; Daniel RT; Messerer M
    Biomed Res Int; 2015; 2015():267831. PubMed ID: 26146614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atypical and malignant intracranial meningiomas].
    Gelabert-González M; Fernández-Villa JM; Iglesias-Pais M
    Rev Neurol; 2004 Feb 16-29; 38(4):304-10. PubMed ID: 14997451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple usages for antiprogestins].
    Heikinheimo O
    Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093
    [No Abstract]   [Full Text] [Related]  

  • 29. Current management of meningiomas.
    De Monte F
    Oncology (Williston Park); 1995 Jan; 9(1):83-91, 96; discussion 96, 99-101. PubMed ID: 7718443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical use of octreotide in unresectable meningiomas. A report of three cases.
    García-Luna PP; Relimpio F; Pumar A; Pereira JL; Leal-Cerro A; Trujillo F; Cortés A; Astorga R
    J Neurosurg Sci; 1993 Dec; 37(4):237-41. PubMed ID: 7931648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of breast carcinoma and meningioma: report of nine new cases and review of the literature.
    Salvati M; Cervoni L
    Tumori; 1996; 82(5):491-3. PubMed ID: 9063531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.
    Perrault D; Eisenhauer EA; Pritchard KI; Panasci L; Norris B; Vandenberg T; Fisher B
    J Clin Oncol; 1996 Oct; 14(10):2709-12. PubMed ID: 8874331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extracranial meningioma. Apropos of 7 cases; pathogenic, diagnostic and therapeutic problems].
    Levy C; Wassef M; George B; Popot B; Compere A; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1988; 105(1):13-21. PubMed ID: 3358602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab.
    Ly KI; Hamilton SR; Rostomily RC; Rockhill JK; Mrugala MM
    J Neuroophthalmol; 2015 Dec; 35(4):382-6. PubMed ID: 26049681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial meningiomas: an overview of diagnosis and treatment.
    Rockhill J; Mrugala M; Chamberlain MC
    Neurosurg Focus; 2007; 23(4):E1. PubMed ID: 17961033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma knife radiosurgery in the management of cavernous sinus meningiomas.
    Roche PH; Régis J; Dufour H; Fournier HD; Delsanti C; Pellet W; Grisoli F; Peragut JC
    J Neurosurg; 2000 Dec; 93 Suppl 3():68-73. PubMed ID: 11143266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory evidence for the hormonal dependency of meningiomas.
    Olson JJ
    Hum Reprod; 1994 Jun; 9 Suppl 1():195-201. PubMed ID: 7962465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hydroxyurea treatment for unresectable meningioma].
    Fuentes S; Chinot O; Dufour H; Paz-Paredes A; Métellus P; Barrie-Attarian M; Grisoli F
    Neurochirurgie; 2004 Sep; 50(4):461-7. PubMed ID: 15547484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature.
    Amirjamshidi A; Mehrazin M; Abbassioun K
    Childs Nerv Syst; 2000 Jul; 16(7):406-16. PubMed ID: 10958549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
    Chamberlain MC; Glantz MJ; Fadul CE
    Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.